LYON, France & PHILADELPHIA--(BUSINESS WIRE)--ERYtech Pharma is pleased to announce it has signed an exclusive long term agreement with Teva for the registration, marketing, distribution and sale of Graspa®, the company’s lead product, in Israel.
LYON, France & PHILADELPHIA--(BUSINESS WIRE)--ERYtech Pharma is pleased to announce it has signed an exclusive long term agreement with Teva for the registration, marketing, distribution and sale of Graspa®, the company’s lead product, in Israel.